Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: Global

iShares Global Healthcare ETF

+ Add to Watchlist

IXJ:AU

137.5700 AUD 0.7100 0.52%

As of 23:30:58 ET on 03/05/2015.

Snapshot for iShares Global Healthcare ETF (IXJ)

Open: 137.7400 High - Low: 138.9000 - 137.4700 Primary Exchange: ASE
Volume: 5,699 52-Week Range: 92.3400 - 138.9000 Beta vs SGHNW: 0.8645

ETF Chart for IXJ

No chart data available.
  • IXJ:AU 137.5700
  • 1D
  • 1M
  • 1Y
136.8600
Interactive IXJ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IXJ

iShares Global Healthcare ETF is an exchange-traded fund incorporated in the USA. The ETF tracks the S&P Global Healthcare Index. The ETF holds global large- cap health care stocks. Its investments are focused in pharmaceutical, biotech, and medical device companies, with its largest allocation to the United States. A market capitalization methodology is used for weighting.

Inception Date: 2009-03-12 Telephone: 1-415-670-2000
Managers: GREG SAVAGE / DIANE HSIUNG
Web Site: www.ishares.com

Fundamentals for IXJ

NAV -
Assets (M) (on 2015-03-05) 1,627.0000
Shares out (M) 9.15
Market Cap (M) 1,260.41
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for IXJ

Dividend Type Income
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-12-22) 0.3858
Dividend Yield (ttm) 1.10%

Performance for IXJ

1-Month +4.31% 1-Year +33.55%
3-Month +10.95% 3-Year +38.72%
Year To Date +11.34% 5-Year +21.13%
Expense Ratio 0.48

Top Fund Holdings for IXJ

Filing Date: 03/03/2015
Name Position Value % of Total
Johnson & Johnson 1,066,863 109,182,759 6.800%
Novartis AG 1,031,109 102,031,514 6.355%
Pfizer Inc 2,401,578 82,998,536 5.169%
Roche Holding AG 267,852 72,539,472 4.518%
Merck & Co Inc 1,086,558 63,389,794 3.948%
Gilead Sciences Inc 575,094 59,113,912 3.682%
Bayer AG 315,120 46,328,996 2.885%
Amgen Inc 289,971 45,977,802 2.864%
GlaxoSmithKline PLC 1,858,299 44,302,614 2.759%
Sanofi 458,439 44,177,749 2.751%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil